M&A Deal Summary

Medtronic Acquires Intersect ENT

On August 6, 2021, Medtronic acquired medical products company Intersect ENT for 1.1B USD

Acquisition Highlights
  • This is Medtronic’s 50th transaction in the Medical Products sector.
  • This is Medtronic’s 5th largest (disclosed) transaction.
  • This is Medtronic’s 43rd transaction in the United States.
  • This is Medtronic’s 21st transaction in California.

M&A Deal Summary
Date 2021-08-06
Target Intersect ENT
Sector Medical Products
Buyer(s) Medtronic
Deal Type Add-on Acquisition
Deal Value 1.1B USD
Advisor(s) Goldman Sachs (Financial)
Cooley (Legal)

Target

Intersect ENT

Menlo Park, California, United States
Intersect ENT is a medical technology company dedicated to advancing the treatment of ear, nose, and throat (ENT) conditions through evidence-based innovation, providing physicians with solutions to overcome clinical challenges and improve the quality of life for patients. Intersect ENT was founded in 2003 and is headquartered in Menlo Park, California.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Medtronic

Dublin, Ireland
Category Company
Founded 1949
Sector Medical Products
Employees95,000
Revenue 32.4B USD (2024)
DESCRIPTION
Medtronic's operational headquarters in Fridley, Minnesota.
Medtronic's operational headquarters in Fridley, Minnesota.

Medtronic is a global medical technology company whose products aim to alleviate pain, restore health, and extend life. It serves hospitals, physicians, clinicians, and patients in approximately 160 countries worldwide. Medtronic was founded in 1949 and is based in Dublin, Ireland with its operational headquarters in Fridley, Minnesota.

DEAL STATS #
Overall 57 of 59
Sector (Medical Products) 50 of 52
Type (Add-on Acquisition) 55 of 57
State (California) 21 of 21
Country (United States) 43 of 44
Year (2021) 1 of 1
Size (of disclosed) 5 of 36
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-09-30 Avenu Medical

San Juan Capistrano, California, United States

Avenu Medical, Inc. is a medical device company, focused on the endovascular (minimally invasive) creation of arteriovenous (AV) fistulae for patients with end-stage renal disease (ESRD) undergoing dialysis. Avenu Medical was established in 2010 and is based in San Juan Capistrano, California.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-01-10 Affera

Newton, Massachusetts, United States

Affera is a medical technology company dedicated to delivering unrivaled innovative solutions to address the rapidly growing demands for cardiac arrhythmia treatment. Affera is developing a comprehensive integrated platform to efficiently deliver durable therapy for a broad set of cardiac arrhythmia patients. Affera is based in Newton, Massachusetts.

Buy -
Mergr

Product

Company

Legal